Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.50    -28.50 (-3.25%)
Bid:
852.50
Ask:
854.50
Spread: 2.00 (0.235%)
Market Cap: £978.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Acquisition of RapidIT-Cloudbera, Inc.

3 Jul 2023 07:00

RNS Number : 2732E
Kainos Group plc
03 July 2023
 

RNS REACH

03 July 2023

 

Kainos Group plc

 

("Kainos" or the "Company")

 

Acquisition of RapidIT-Cloudbera, Inc.

 

Kainos Group plc (KNOS), a UK-headquartered IT provider with expertise across three divisions - Digital Services, Workday Services, and Workday Products, today announces the acquisition of RapidIT-Cloudbera, Inc. ("RapidIT-Cloudbera").

 

Established in 2017, RapidIT-Cloudbera is the creator of Genie, a Workday-focused automated testing product which has the ability to rapidly auto-generate test cases, allowing customers to quickly launch their automated testing efforts. Genie is used by over 100 organisations to streamline their testing activity.

 

Kainos will combine Genie with its own market-leading automated testing product, Smart Test, which will provide customers the ability to achieve greater compliance and quality assurance - more quickly, with less internal effort and with increased testing coverage. Integration of the products is due to complete during Kainos' current financial year.

 

In its most recent results, Kainos re-confirmed its ambition for the Smart products suite, which includes Smart Test. Reporting Annual Recurring Revenue (ARR) of £49m at 31 March 2023, the Smart products suite is forecast to achieve £100m ARR by 2026.

 

RapidIT-Cloudbera is headquartered in Atlanta, US, and has operations in the US and India employing 101 people. The team at RapidIT-Cloudbera will join the Kainos Workday Products division.

 

The terms of the acquisition have not been disclosed.

 

Brendan Mooney, CEO of Kainos, commented:

"We are delighted to welcome our new colleagues from RapidIT-Cloudbera. The skills, expertise and creativity of our expanded team will allow us to accelerate our product development, increasing the functionality of our existing products and allowing us to quickly bring new products to market - it is a winning combination."

 

Gopo Velagundula, CEO of RapidIT-Cloudbera commented:

"The automated testing market for Workday is growing rapidly and by combining our two products we are creating the undisputed global leader for automated testing. The combination also represents fantastic news for our customers, increasing the scale and value of what we can do to support their compliance efforts."

 

Malachy Smith, Workday Products Director at Kainos:

"When we launched Smart Test in 2013 we created the market for the automated testing of Workday and it has been incredibly exciting to be at the forefront of this market for the past ten years. The combination of Smart Test and Genie further enhances our position in this high growth market and allows us to look beyond our £100m ARR target."

 

 

Ends

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Ben Griffiths

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Dwight Burden / Kwaku Aning 

 

About Kainos  

 Kainos Group plc is a UK-headquartered IT provider with expertise across three divisions: Digital Services, Workday Services, and Workday Products. 

 

· Digital Services develops and supports custom digital service platforms for public sector, commercial, and healthcare customers. Our solutions transform the delivery of these services, ensuring they are secure, accessible, and cost-effective, and provide better outcomes for users. 

 

· Workday Services specialises in the deployment of Workday, Inc.'s Finance, HR and Planning products to leading organisations across Europe and North America. We are one of Workday's most respected partners, experienced in complex deployment and trusted by our customers to launch, test, expand, and support their Workday systems. 

 

· Workday Products develops products that complement Workday. Our Smart product suite, including Smart Test (for automated testing), Smart Audit (for compliance monitoring), and Smart Shield (for data masking), are used by more than 350 customers globally to safeguard their Workday systems. 

 

Our people are central to our success. We employ more than 2,900 people in 22 countries across Europe and the Americas. 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFIVRLITFIV
Date   Source Headline
4th Jun 202611:31 amRNSDirector / PDMR shareholdings
1st Jun 202610:27 amRNSTotal Voting Rights
18th May 20267:00 amRNSFull Year Results
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 202611:06 amRNSTotal Voting Rights
28th Apr 20261:38 pmRNSBoard and Board Committee Changes
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSYear-end Trading Update
14th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:22 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20265:10 pmRNSDirector Declaration
24th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20263:16 pmRNSNotification of Major Holdings
17th Mar 202611:28 amRNSDirector/PDMR shareholdings
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20264:58 pmRNSNotification of Transactions of Director/PDMR
12th Mar 20262:13 pmRNSHolding(s) in Company
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:30 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20269:43 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.